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Objectives. This study sought to determine the long-term (>15
years) outcome of a clinically well characterized cohort of African
Americans with known or suspected coronary artery disease
(CAD).
Background. The mortality rate from CAD is higher in African
Americans than in whites. An earlier analysis of data from the
Coronary Artery Surgery Study (CASS) registry suggested that
African American and white patients treated surgically had equal
5-year survival rates.
Methods. Survival data from the CASS registry were analyzed
to determine whether 1) African American race is an independent
predictor of mortality; and 2) initial therapy is predictive of
mortality among African American patients.
Results. Overall, 60% of white and 52% of African American
patients survived 16 years (p < 0.00001). Multivariate Cox models
confirmed that African American race was independently associ-
ated with higher mortality in both the medical group (hazard ratio
[HR] 1.34, 95% confidence interval [CI] 1.11 to 1.63) and the
surgical group (HR 1.63, 95% CI 1.19 to 2.23). Initial therapy was
not predictive of survival among African American patients (p 5
0.81). However, smoking status significantly influenced survival:
African Americans who did not smoke experienced significantly
improved survival (60% vs. 48% for smokers), which equaled
survival for white nonsmokers (61%, p 5 NS).
Conclusions. In contrast to results from shorter term studies,
African Americans experienced higher overall mortality rates
than whites over the long term, regardless of the type of initial
treatment. Survival among nonsmoking African Americans at 16
years equaled survival among nonsmoking whites.
(J Am Coll Cardiol 1997;29:358–64)
q1997 by the American College of Cardiology
Higher mortality from coronary artery disease (CAD) occurs
among African Americans than white Americans, especially in
the younger age groups (1–3). One potential contributing
cause is lower utilization of invasive care in management of
CAD in African Americans (4–7). Using data from the Throm-
bolysis in Myocardial Infarction Phase II (TIMI II) trial, we
reported (8) that equal access to urgent interventions and
revascularization (including operation) resulted in equal sur-
vival rates 1 year after acute myocardial infarction, the leading
cause of death from CAD. Furthermore, others, including the
Coronary Artery Surgery Study (CASS) investigators, have
reported (9,10) that surgical therapy produced equal survival
in African American and white patients with CAD up to 5
years after operation. To examine the long-term survival of
African Americans with known or suspected CAD, we ana-
lyzed data from the CASS registry 16 years after patient
enrollment.
Methods
Patient population. Details of the CASS design, methods,
definition of terms and baseline data have been reported
previously (11). Fifteen clinical centers enrolled patients un-
dergoing coronary angiography between 1974 and 1979. The
study was approved by each center’s institutional review board,
and all patients gave written informed consent. Patients who
had undergone cardiac surgery (except for pacemaker surgery)
before enrollment and those of races other than African
American or white were excluded from this analysis. The
sample included 571 African Americans and 22,754 whites.
Follow-up. The CASS registry participants were contacted
annually through 1982. To obtain data at least 10 years after
enrollment, a follow-up questionnaire was administered by
mail between 1988 and 1991, with vital status determined in
94% participants. Vital status through 1992 was also deter-
mined by searching the National Death Index. Patients with no
death record were considered alive as of December 31, 1992.
The mean follow-up period was 12.0 6 5.2 years for African
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Americans and 12.7 6 4.9 years for whites, with a maximum of
18 years for both groups.
Data analysis. The clinical characteristics of patients sur-
viving $10 years with complete follow-up data were compared
by the Pearson chi-square test and, where appropriate, the
chi-square test for trend. Patients who died before the 1988
follow-up contact or did not complete a questionnaire were
necessarily excluded from this analysis.
Survival curves were estimated by the Kaplan-Meier
method and compared by the log-rank statistic. Stratified
analyses were used to adjust for important baseline character-
istics.
Cox proportional hazards models were used to determine
the independent effect of race on survival in patients treated
with medicine or operation and to assess the effect of type of
therapy on survival in African Americans. First, all covariates
except the variable of interest were considered in a stepwise
Cox regression analysis. After this model was constructed, the
variable of interest (race or therapy) was allowed to enter if it
offered additional predictive power. Validity of the propor-
tional hazards assumption was confirmed by stratified models.
Variables considered in the multivariate models are shown
in Table 1. Initial therapy and survival times for medical and
surgical group patients were defined as follows: Patients were
considered to be surgically treated if they underwent coronary
artery bypass graft surgery (CABG) within the time period at
each center within which 95% of the CABG procedures in the
first year occurred; all others were assigned to the medical
group. The data of CABG was the starting point for calculation
of survival time in the surgical group. For medical patients,
survival time was calculated from the date of enrollment plus
the average time to operation at each center. This calculation
adjusts for the discrepancy in exposure time between the
medical and surgical groups. Patients who died before reaching
the average time to operation at that center were excluded.
Medical group patients who subsequently underwent CABG
remained in the medical group.
Results
Baseline characteristics. Descriptive data for African
Americans and whites in the CASS registry at enrollment have
been published previously (12). That initial survey of baseline
features revealed that more African Americans had hyperten-
sion and diabetes and were current smokers than was true for
the whites; however, whites were more likely to be heavy
smokers (.2 packs/day). Also, white men more frequently had
a history of a documented myocardial infarction. With respect
to symptomatology, significantly more African Americans fell
into the “no angina” category and significantly fewer African
Americans who had angina pectoris reported Canadian Car-
diovascular Society (CCS) class III or IV symptoms. Also,
substantially more African American than white patients had
no “significant” coronary stenoses (at least 70% narrowing of
any of the three main epicardial arteries or their branches or at
least 50% stenoses of the left main coronary artery). Forty-
seven percent of African American men and 67% of African
American women fell into the “no CAD” category compared
with 20% and 55% of white men and women, respectively.
Ten-year survivors. The key features of CASS registry
patients who were alive and available for follow-up 10 years
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAD 5 coronary artery disease
CASS 5 Coronary Artery Surgery Study
CCS 5 Canadian Cardiovascular Society
CI 5 confidence interval
HR 5 hazard ratio
PTCA 5 percutaneous transluminal coronary angioplasty
Table 1. Variables Considered for Entry Into Cox Proportional
Hazards Models
Variable Definition
Age Age at angiography
Gender Male/female
Smoking at baseline Never, former, current
Smoking at anytime (including
follow-up)
Yes/no
Hypertension Yes/no
Diabetes Yes/no
No. of associated medical
conditions
0–13
Previous MI None, single, multiple
History of CHF Yes/no
CHF score 0–4 (no–severe CHF)
Functional impairment due to CHF 0–4 (no CHF–severe impairment)
Recreational activity 1–4 (strenuous–sedentary)
CCS class 0–4 (0 5 no angina; 1–4 5 class I–IV)
Unstable angina 0–2 (0 5 no angina; 1 5 stable angina;
2 5 unstable angina)
Normal arteriogram Yes/no (yes 5 entire coronary
vasculature normal)
No. of diseased vessels 0–3
No. of diseased proximal vessels 0–3
Myocardial jeopary index 0–3 (0 5 no jeopardized LV segments;
1 5 inferior wall jeopardy; 2 5
anterior wall jeopardy; 3 5 both
segments jeopardized)
LV wall motion score 5–30 (5 5 normal left ventricle)
LMCA disease Percent obstruction at baseline
Ejection fraction At baseline
LV end-diastolic pressure At baseline
Nitroglycerin Yes/no
Beta-blockers Yes/no
Digitalis Yes/no
Diuretic drugs Yes/no
Employment Laborer/clerical/professional/homemaker
Race White/black
Initial therapy Medical/surgical
CCS 5 Canadian Cardiovascular Society; CHF 5 congestive heart failure;
LMCA 5 left main coronary artery; LV 5 left ventricular; MI 5 myocardial
infarction.
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after enrollment are shown in Table 2. African Americans had
a higher prevalence of hypertension (69% vs. 40%, p ,
0.0001), diabetes mellitus (35% vs. 17%, p , 0.0001) and
current smoking (28% vs. 21%, p 5 0.003) than whites. In
contrast to the findings at baseline, more African Americans
than whites complained of chest pain (69% vs. 61%, p 5 0.01)
and reported use of nitroglycerin (73% vs. 62%, p 5 0.003).
Furthermore, proportionately more African Americans re-
ported CCS class III or IV angina pectoris than did their white
counterparts.
Risk factor modification. Table 2 also shows the frequency
of certain risk factor reduction strategies among African
American and white survivors at 10 years. Whites more
frequently than African Americans were taking aspirin (50%
vs. 38%, p 5 0.0002) and actively dieting to lower cholesterol
(49% vs. 42%, p 5 0.03). The use of estrogen replacement
therapy was significantly more common among white women
than among African American women (41% vs. 23%, p 5
0.0006).
Cause of death. The cause of death was determined for
8,428 CASS registry patients who died during the first 16 years
(94% of all deaths). The cause was cardiac related in 6,403
deaths (76% of classifiable deaths). The proportion of deaths
due to cardiac-related causes was similar between the two
racial groups (75% among African Americans vs. 76% among
whites).
Predictors of survival in African Americans. Age, left
ventricular wall motion score, smoking at baseline and number
of diseased vessels were the strongest predictors of mortality
for African American patients. Univariate analyses illustrate
the effects of these variables. Only 42% of African American
patients .55 years old at enrollment survived 16 years, com-
pared with 72% for those who were #45 years old at enroll-
ment. Impaired left ventricular function, as indicated by wall
motion score, also had a profound effect on 16-year survival in
African American patients, with the survival rate being 29%
for those with severely abnormal wall motion, 67% for those
with normal left ventricular function and 61% for those with
moderate impairment. Only 48% of smokers survived 16 years
compared with.60% for nonsmokers. Seventy-four percent of
patients without any diseased coronary vessels survived 16
years compared with only 24% of those with three-vessel
disease. However, the form of initial therapy had no impact on
16-year survival after adjusting for significant covariates (Table
3).
Effect of race on survival. Overall age-adjusted 16-year
survival was better in whites than in African Americans (Fig.
1). After adjusting for significant clinical and treatment vari-
ables, African American race was still a strong independent
predictor of mortality in both treatment groups. During 16
years of follow-up, African Americans treated medically were
34% more likely to die than whites (hazard ratio [HR] 1.34,
95% confidence interval [CI] 1.11 to 1.63); those treated
surgically were 63% more likely to die than whites (HR 1.63,
95% CI 1.19 to 2.23), (Fig. 2, Table 4).
Figure 1. Age-adjusted survival in African Americans and whites in
the CASS registry. Numbers below x-axis 5 number of patients at risk
and the percentages surviving at years after entry indicated.
Table 2. Comparison of Follow-Up Variables in African Americans
and Whites
10-Yr F/U Variable
Whites
[no. (%)]
African
Americans
[no. (%)]
p
Value
Chest pain 8,575 (61%) 180 (69%) 0.01
Use of nitroglycerin in past year 5,194 (62%) 129 (73%) 0.003
CCS class 0.0006
No angina 5,522 (43%) 84 (38%)
I 1,546 (12%) 20 (9%)
II 3,008 (23%) 48 (21%)
III 930 (7%) 15 (7%)
IV 1,934 (15%) 57 (25%)
Limitation of activities 0.41
None 4,541 (33%) 75 (32%)
Intermittent 1,633 (12%) 23 (10%)
Mild 2,582 (19%) 49 (21%)
Moderate 3,126 (23%) 63 (27%)
Severe 1,667 (12%) 27 (11%)
Hypertension 5,120 (40%) 174 (69%) ,0.0001
Diabetes 1,926 (17%) 74 (35%) ,0.0001
Cerebrovascular disease 749 (7%) 24 (12%) 0.003
Aspirin for heart disease 7,068 (50%) 100 (38%) 0.0002
Diet to lower cholesterol 6,498 (49%) 100 (42%) 0.03
Cholesterol medications 2,081 (16%) 27 (12%) 0.11
Smoked cigarettes in last year 2,886 (21%) 73 (28%) 0.003
Use of estrogen (women only) 1,380 (41%) 21 (23%) 0.0006
CCS 5 Canadian Cardiovascular Society; F/U 5 follow-up.
Table 3. Multivariate Predictors of Survival for 530 African
Americans in the CASS Registry
Variable Chi-Square p Value
Age 29.56 ,0.0001
LV wall motion score 23.69 ,0.0001
Smoking at baseline 18.85 ,0.0001
No. of diseased vessels 16.04 0.0001
Diabetes 10.48 0.0012
CHF score 9.23 0.0024
Clerical worker (reduced risk) 5.08 0.0242
Therapy 0.06 0.81
Abbreviations as in Table 1.
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Stratified survival analyses (Table 5). Stratified survival
function analyses were performed to further examine the
impact of key predictors of mortality in patients in the two
racial groups in the CASS registry. African American patient
survival was worse in the younger age categories. Long-term
survival for women did not differ between the races, whereas
African American men had significantly worse survival than
their white counterparts.
African American smokers had significantly worse survival
than their white counterparts. There was no difference in
survival between African American and white patients who
either never smoked or who had quit smoking before entering
the study. The Kaplan-Meier survival curves shown in Figure 3
illustrate the impact of smoking on survival in the two racial
groups over the 16 years of follow-up.
Hypertensive status affected survival in both groups. How-
ever, the survival rate of hypertensive African Americans was
not significantly different from that of hypertensive whites.
Diabetes mellitus worsened survival for both African Ameri-
can and white patients.
African American and white patients without angina had
equally good survival rates. However, African American pa-
tients with angina of any severity had poorer survival than
whites in the corresponding CCS class.
Differences in survival between African American and
white CASS registry patients were also evident in a variety of
angiographically defined subgroups. African American patient
mortality exceeded white patient mortality in the one-, two- or
three-vessel coronary artery disease categories. African Amer-
ican patients with no CAD also had worse survival than their
white counterparts. Left ventricular wall motion score results
suggest that among patients with the mildest left ventricular
dysfunction, proportionally more African Americans died over
the 16 years after study entry (p , 0.0005). No significant
differences emerged between African American and white
patients with similar ejection fractions. Among patients with
the most severe congestive heart failure, African American
survival was better than that of the white patient group.
Discussion
Our analysis of follow-up data from the CASS registry
suggests that despite similar survival rates for African Ameri-
can and white patients 5 years after operation (10), profound
differences in survival emerge between the two groups by 16
years after operation. Furthermore, surgical therapy was not
associated with improved survival for African American pa-
tients at 16 years after operation as it had been at the earlier
follow-up evaluation. The higher African American patient
mortality in both the medical and surgical treatment groups is
disappointing and raises questions about factors that influence
long-term survival of African American patients.
The significantly higher prevalence of classical risk factors
among African Americans in the CASS registry reflects rates
seen in the general African American population. These
characteristics are not only risk factors for CAD in native
vessels, but also hasten the occlusion of coronary artery bypass
grafts, thus placing the African American group at risk for a
poorer long-term outcome regardless of treatment. In our
analysis, these factors did not account for all of the disparity in
survival rates; however, their influence on African American
patient survival is evident.
Smoking, in particular, had a disproportionally profound
effect on survival of African American patients. In the absence
of smoking, survival rates are relatively high and equivalent for
African Americans and whites. However, African Americans
who were smokers at entry have a much reduced chance of
long-term survival than their white counterparts. This finding
suggests that smoking is a particularly lethal practice for
African Americans. Interestingly, others have noted dispropor-
tionately high mortality among African American smokers
from other diseases as well (13,14). These differences in
tobacco-related mortality are poorly understood; however,
racial differences in the details of the smoking habit (i.e., brand
selection, nuances of inhaling, amount of tobacco smoked per
cigarette, less success of African Americans in smoking cessa-
tion, as well as possible differences in metabolism of toxins
found in cigarette smoke) may play a role in the excess
mortality found among African American smokers in the
CASS registry (15). Neither serum cotinine levels nor detailed
Figure 2. Age-adjusted survival in African Americans and whites. Top,
medical treatment strategy. Bottom, Surgical treatment strategy. Num-
bers below x-axis5 numbers and percentages of patients at years after
entry indicated.
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quantification of cigarettes smoked were obtained in the
present study.
Differences in the effectiveness of the CABG procedure in
African Americans and whites appear unlikely; however, re-
cent data suggest that the highly effective left internal mam-
mary artery bypass graft may be used less frequently among
African Americans undergoing CABG (16). If such a differ-
ence in the specifics of the bypass procedure occurred for black
and white patients in the CASS registry, long-term survival
among black patients could have suffered as a result.
Access to care. Despite access to coronary angiography and
surgical therapy at the time of enrollment into the CASS
registry, African American patients may have experienced
impaired access to longitudinal care for CAD. Although the
CASS design provided for periodic monitoring of a variety of
patient clinical and treatment variables, ongoing care was left
to the patient’s usual resources and behavior. Barriers to
primary care (17) and invasive care (4,6,7,18) for African
Americans have been documented previously by many inves-
tigators. That less comprehensive care was given to the African
American patients enrolled in the CASS registry is suggested
by the lower rates of secondary prevention efforts reported by
African American 10-year survivors. The 10-year survivor data
suggest a race-associated disparity in utilization of secondary
prevention strategies. However, these data must be interpreted
with caution. The results may be biased by the fact that data
are available from survivors only, giving us no insight into the
level of care provided those patients who died before 10 years
in the study. Furthermore, response rates to the survey may
differ by race. Nevertheless, a pattern of responses consistent
with other reports documenting poor access to care for African
American patients emerges from the 10-year survivor data.
Fewer African Americans reported using daily aspirin or
modifying their diets to lower cholesterol, and more were
smoking. Estrogen-replacement therapy was used sparingly
among African American women. The findings are particularly
worrisome given that more African Americans had clinically
obvious ischemia, as indicated by a heavier dependence on
nitroglycerin for angina pectoris. Also, the higher prevalence
of CAD risk factors (diabetes, hypertension, smoking and
evidence of cerebrovascular disease) among African American
survivors suggests that they should have been receiving more,
rather than less, secondary prevention therapy.
Limitations of the study. Some limitations of the study
have been mentioned. Additionally, it should be recalled that
the number of African American patients in the CASS registry
is relatively small, especially 16 years after enrollment. How-
ever, this series is unique in that it offers the advantage of
long-term follow-up of a group of African American patients
with CAD for whom a substantial amount of clinical informa-
tion is available.
Another possible limitation is that the initial data for CASS
were obtained in the era preceding the wide availability and
utilization of thrombolytic therapy and percutaneous translu-
Table 4. Multivariate Predictors of Survival for Medical and Surgical Group Patients in the
CASS Registry
Variable
Medical Group
(n 5 9,724)
Surgical Group
(n 5 5,977)
Chi-Square p Value Chi-Square p Value
Age 440.50 ,0.0001 227.67 ,0.0001
No. of diseased vessels 89.57 ,0.0001 40.87 ,0.0001
Smoking at baseline 106.04 ,0.0001 40.93 ,0.0001
LV wall motion score 88.09 ,0.0001 36.64 ,0.0001
Ejection fraction 51.55 ,0.0001 23.64 ,0.0001
Diabetes 90.66 ,0.0001 42.53 ,0.0001
LV end-diastolic pressure 38.18 ,0.0001 19.30 ,0.0001
CHF score 51.19 ,0.0001 20.87 ,0.0001
Gender 29.81 ,0.0001 * *
Recreational activity 20.57 ,0.0001 * *
Normal arteriogram 22.08 ,0.0001 * *
Functional impairment 17.46 ,0.0001 * *
LMCA disease 21.20 0.0001 8.16 0.004
Hypertension 31.76 ,0.0001 29.23 ,0.0001
Smoking at F/U 13.87 0.0002 * *
Diseased proximal vessels 4.89 0.03 * *
CHF 5.36 0.02 * *
Black race 8.87 0.003 9.17 0.003
No. of illnesses † † 25.70 ,0.0001
Laborer † † 25.93 ,0.0001
Digitalis † † 6.39 0.01
HR (95% CI) for black vs. white mortality 1.34 (1.11–1.63) 1.63 (1.19–2.23)
*Variable not a significant predictor of survival for surgical group patients. †Variable not a significant predictor of
survival for medical group patients. CI 5 confidence interval; HR 5 hazard ratio; other abbreviations as in Tables 1 and 2.
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minal coronary angioplasty (PTCA). We consider this concern
to be a minor one in that CABG is still a prominent modality
for the management of CAD, and examination of its long-term
results in African Americans and whites is appropriate and
timely. Also, the key advantage of the present study (i.e.,
long-term survival analysis) requires that we evaluate interven-
tions made before PTCA and thrombolysis were commonly
used. The impact of PTCA or thrombolysis, or both, on the
divergent long-term mortality data for African Americans and
whites in the CASS registry was not assessed directly by this
analysis. However, given the acknowledged lower utilization of
these interventions among African American patients with
CAD (4,6), it is possible that uneven utilization of these
revascularization techniques contributed to the disparate 16-
year outcome.
Summary. Coronary artery disease is the most frequent
cause of death among African American and white Americans.
Access to major cardiovascular interventions for all patients
who need them is an important goal in our health care system’s
efforts to optimize CAD care. However, although surgical
intervention provides encouragingly similar survival patterns
between African American and white patients for a few years,
16-year follow-up data from the CASS registry suggest that
operation alone does not produce a sustainable improvement
in survival rates among African American patients. Significant
racial differences in risk factor modification were suggested by
these data. The smoking habit profoundly worsened mortality
among African American patients; in the absence of smoking,
there was no difference in survival between the racial groups.
Access to comprehensive long-term care with special emphasis
on smoking cessation is critically important in efforts to
improve the prognosis for African American patients at risk
for death from CAD. Without such services, the potential
long-term survival benefits that access to CABG or other
invasive procedures provide will most likely be lost.
We thank Selina Todd for expert preparation of the manuscript.
Table 5. Stratified Survival Analyses in African Americans
and Whites
Variable and
Subgroup
16-Year Survival Rates
p
ValueWhites African Americans
Age (yr)
,45 77% 72% 0.05
45–55 66% 54% ,0.0001
.55 46% 42% 0.13
Gender
Women 69% 66% 0.23
Men 57% 52% 0.02
Hypertension
No 64% 65% 0.91
Yes 52% 53% 0.67
Diabetes
No 62% 61% 0.40
Yes 40% 38% 0.38
Smoker
Never 66% 68% 0.61
Former 58% 61% 0.72
Current 57% 48% 0.0004
CCS class
No angina 69% 72% 0.55
I/II 63% 46% ,0.0001
III/IV 51% 43% 0.008
No. of diseased vessels
0 83% 74% ,0.0001
1 65% 51% 0.0005
2 53% 38% 0.0025
3 39% 24% 0.0001
Ejection fraction
#50% 39% 36% 0.36
.50% 68% 65% 0.09
LV wall motion score
5 75% 67% 0.0005
6–9 59% 61% 0.89
$10 35% 29% 0.06
CHF score
None 68% 67% 0.47
Mild 54% 48% 0.07
Mod/severe 27% 42% 0.01
Mod 5 moderate; other abbreviations as in Table 1.
Figure 3. Age-adjusted survival in African Americans and whites. Top,
Current smokers at baseline. Bottom, Never/former smokers at base-
line. Numbers below x-axis 5 numbers and percentages of patients at
years after entry indicated.
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